SWOG S1900E – A LUNG MAP Treatment Trial

A Phase II Study Of AMG 510 In Participants With Previously Treated Stage IV Or Recurrent KRAS G12c Mutated Non-Squamous Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)

For more information about this clinical trial, click here

Schema & Eligibility SWOG S1900E – LUNG-MAP Sub-study

Available at:

CoxHealth Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Delbert Day Cancer Institute at PCRMC, Rolla, MO
Freeman Health System, Joplin, MO
Good Samaritan Regional Health Center, Mt. Vernon, IL
Mercy Hospital, St. Louis, MO
Mercy South, St. Louis, MO
Mercy Hospital, Oklahoma City, OK
Mercy Hospital, Fort Smith, AK
Mercy Hospital, Joplin, MO
Mercy Clinic Cancer & Hematology, Rolla, MO
Mosaic Life Care, St. Joseph, MO

Ask your physician about participating in this clinical trial or call us.